Notably, FR-α stimulates the proliferation of hepatocellular carcinoma (HCC) cells via the PI3K/Akt signaling pathway, positioning it as a promising and effective target for liver cancer therapy (Juliano, 2016). Here, AKT1 is linked to hepatocellular carcinoma.